한국어
  1. Map
  2. Osaka
  3. 医療法人社団医進会 大阪小田クリニック

医療法人社団医進会 大阪小田クリニック

Visitor policy unverifiedOsaka

Matches the official registry and the clinic's site describes self-pay GLP-1 care. We could not find its policy on visitors. Ask the clinic before you go.

What we verified

Each item shows the source and the date we checked the clinic's official site. Items without evidence are marked 'Unverified'.

GLP-1 (Mounjaro) self-pay treatment
YesSource: ishinkai-ooc.net (new window) · Checked 2026-11-14
Accepts visitors
Unverified
Korean support
Unverified
Same-day visit
Unverified
Hotel delivery
Unverified
In-clinic pickup
Yes
English prescription / letter
Unverified

Prices published by the clinic

Copied from the clinic's site. Consultation and delivery fees may be extra; prices change.

ItemJPYTaxChecked
マンジャロ2.5mg 1本¥5,000n/a2026-11-14 · Source (new window)
2.5mg 4本セット¥18,000n/a2026-11-14 · Source (new window)
5mg 4本セット¥33,000n/a2026-11-14 · Source (new window)
7.5mg 1本¥12,000n/a2026-11-14 · Source (new window)
10mg 1本¥15,000n/a2026-11-14 · Source (new window)
12.5mg 1本¥18,000n/a2026-11-14 · Source (new window)
15mg 1本¥20,000n/a2026-11-14 · Source (new window)
初診料(処方する場合は無料)¥3,300n/a2026-11-14 · Source (new window)

Risks to know

GLP-1 injections commonly cause nausea, vomiting, diarrhea and constipation; rare reports include acute pancreatitis, hypoglycemia and vision problems (NAION). In Japan, Mounjaro is approved for type 2 diabetes only; weight-management use is off-label. Medicines prescribed abroad do not appear in Korea's DUR records and are hard to cover under its adverse-reaction relief scheme.

SushiMedi does not advertise clinics or medicines and does not refer patients. Treatment decisions are made by the local doctor. Medicines prescribed abroad are not covered by Korea's adverse-reaction relief scheme. Follow MFDS and Korea Customs rules when bringing medicines home.